These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4400508)

  • 1. Central and peripheral adrenergic blocking actions of LSD and BOL.
    Palmer GC; Burks TF
    Eur J Pharmacol; 1971 Sep; 16(1):113-6. PubMed ID: 4400508
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine.
    Horita A; Hamilton AE
    Science; 1969 Apr; 164(3875):78-9. PubMed ID: 5773714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of mechanisms of the antilipolytic actions produced by alpha and beta adrenergic blocking agents.
    Hynie S; Krishna G; Brodie BB
    Pharmacology; 1969; 2(3):129-37. PubMed ID: 4390572
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggregation of blood platelets by biogenic amines and its inhibition by antiadrenergic and antiserotoninergic agents.
    Barthel W; Markwardt F
    Biochem Pharmacol; 1974 Jan; 23(1):37-45. PubMed ID: 4149367
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative vasoconstrictor potencies of norepinephrine, alpha-methylnorepinephrine and octopamine.
    Kelly RJ; Burks TF
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):306-16. PubMed ID: 4153044
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of isolated sheep umbilical cord blood vessels.
    Dyer DC
    J Pharmacol Exp Ther; 1970 Dec; 175(3):565-70. PubMed ID: 4395224
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine-sensitive adenylate cyclase in rat hypothalamus: effects of adrenergic blockers and narcotics.
    Badger TM; Cicero TJ
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):175-88. PubMed ID: 21429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.
    Persson SA
    Psychopharmacology (Berl); 1978 Oct; 59(2):113-6. PubMed ID: 31650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1973 Jun; 231(2):251-70. PubMed ID: 4352765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacological agents and the cyclic AMP system of rat brain.
    Uzunov P; Weiss B
    Adv Cyclic Nucleotide Res; 1972; 1():435-53. PubMed ID: 4146714
    [No Abstract]   [Full Text] [Related]  

  • 14. Noradrenergic mediation of experimental cerebrovascular spasm.
    Fraser RA; Stein BM; Barrett RE; Pool JL
    Trans Am Neurol Assoc; 1970; 95():21-6. PubMed ID: 4398208
    [No Abstract]   [Full Text] [Related]  

  • 15. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents.
    EVARTS EV
    Ann N Y Acad Sci; 1957 Mar; 66(3):479-95. PubMed ID: 13425237
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current problems in active substance research. 4. Central effects of angiotensin II].
    Hilse H; Piesche L; Scheer E
    Pharmazie; 1974 May; 29(5):303-6. PubMed ID: 4152657
    [No Abstract]   [Full Text] [Related]  

  • 19. MDA: an agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine.
    Glennon RA; Young R
    Eur J Pharmacol; 1984 Mar; 99(2-3):249-50. PubMed ID: 6145599
    [No Abstract]   [Full Text] [Related]  

  • 20. Analeptic action of lysergic acid diethylamide (LSD-25) against pentobarbital.
    APTER JT
    AMA Arch Neurol Psychiatry; 1958 Jun; 79(6):711-5. PubMed ID: 13532082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.